About Life Length
Life Length is a Healthcare company based in Bensalem (United States) founded in 2010 by Stephen J Matlin. Life Length has raised $2.7 million across 6 funding rounds from investors including European Union, EMPLEO COMUNIDAD DE MADRID and EIC Fund. Its chief executive, as recorded, is Stephen J Matlin. Life Length offers products and services including HealthTAV, HealthNAD+, and HealthOX. Its focus areas include Life Sciences, Genomics, Genomics Research and Biomarker Discovery. Its competitors include Metabolon, Maze Therapeutics and Seer; 3 of its 3 listed competitors have raised funding.
Company details
Provides telomere length analysis technology for diagnosis. The company offers its proprietary technology for telomerase length detection for the health and aging process. It offers its services to physicians, individuals, researchers, and corporations. The company is involved in the development of biomarkers and its flagship product ONCOCHECK for clinical validation of Telomere Associated Variables (TAVs) as cancer biomarkers by its TAT technology for prostate cancer.
- Total Equity Funding$2.7M (USD)
in 6 rounds
- Latest Funding Round$2.12M (USD), Grant
Jan 2024
- InvestorsEuropean Union
& 2 more
Products & Services of Life Length
Life Length offers a comprehensive portfolio of products and services, including HealthTAV, HealthNAD+, and HealthOX.
Assesses cellular health and biological age through telomere analysis
Measures NAD+ levels to evaluate cellular energy and aging risks
Analyzes oxidative stress as a key health and metabolism indicator
Apps and channels of Life Length
its YouTube channel LifeLength has 980 subscribers and 30 videos.
Videos from Life Length
The most watched videos on Life Length's YouTube channel, LifeLength (980 subscribers). Click a video to play it here.
More on LifeLength.
Funding Insights of Life Length
Life Length has successfully raised a total of $2.7M across 6 strategic funding rounds. The most recent funding activity was a Grant round of $2.12 million completed in January 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $2.7M
- Total Rounds 6
- Last Round Grant — $2.12M
- First Round $56,465
(Sep 2015)
- Investors Count 3
All 6 funding rounds of Life Length with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2024 | $2.12M | Grant | – | – | |
| Jul 2019 | $2.7M | Seed | – | – | – |
| Dec 2018 | $3.56M | Grant | – | – | |
| Jan 2017 | $3.27M | Grant | – | – | |
| Oct 2015 | $55,006 | Grant | – | – | |
| Sep 2015 | $56,465 | Grant | – | – |
3 investors in total: 3 institutional.
Investors in Life Length
Life Length has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include European Union, EMPLEO COMUNIDAD DE MADRID and EIC Fund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Government agency and accelerator focusing on innovative startups and SMEs | eicfund.eu | Brussels, Belgium | ||
Public services and information are provided for Madrid citizens. | comunidad.madrid | Spain | ||
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium |
Investor details for Life Length
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Life Length
13 people are tracked at Life Length (8 in leadership, 2 in board & advisors, 3 in team).
| Name | Role | Group |
|---|---|---|
Stephen J Matlin | Founder & CEO | Leadership |
Enrique Segovia | CTO & Operations Director | Leadership |
Mónica Parramón | Senior Clinical & Market Access Director | Leadership |
Alfonso Blázquez | Senior Scientist & Laboratory Sub-Director | Leadership |
Javier Antón Arespacochaga | CFO | Leadership |
Jesus Cardenes | Chief Commercial Officer (cco) | Leadership |
Patricia Rader | Administration & HR Director | Leadership |
Dr. Enrique Samper | Chief Business And Transformation Officer | Leadership |
Juan Pablo Rodríguez Castejón | Chairman | Board & advisors |
Inderjeet Dokal | Scientific Advisor | Board & advisors |
Rocío Núñez | Clinical Pathology Manager | Team |
Adrián Asensio Molina | Laboratory Technician | Team |
Adrián Ezequiel Sesto Bejo | Financial Controller | Team |
Complete people profiles for Life Length
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Life Length
3 dated milestones of Life Length across 14 years, from founding to its latest funding, stage changes and deals.
- Founded Life Length is founded.
- Funding First funding round of $56K.
- Funding Latest funding round, Grant, of $2.1M.
Competitors of Life Length
Life Length has 3 listed competitors in our database, 3 of them funded. They include Metabolon, Maze Therapeutics and Seer.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| metabolon.com | 2000 | Morrisville, United States | $165.87M | 189 | Solutions for biomarker discovery and diagnostic testing are provided. | |
| mazetx.com | 2018 | Redwood, United States | $496M | 111 | Genetic biomarkers are developed for neurological, metabolic, and renal diseases. | |
| seer.bio | 2017 | San Francisco, United States | $127.5M | 89 | Proteomics platform developed for early cancer and neurological disease detection. |
Detailed competitors of Life Length
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Life Length
Websites that share an audience with Life Length (lifelength.com).
Websites whose visitors overlap most with Life Length. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
ygyh.org | ygyh.org | 100% | #13,371,229 | – | |
rarechromo.org | rarechromo.org | 98% | #559,777 | – | |
atlasgeneticsoncology.org | atlasgeneticsoncology.org | 98% | #543,257 | – | |
| kailosgenetics.com | 98% | 2.3K | #6,334,797 | View details | |
hgfound.org | hgfound.org | 96% | #4,129,706 | – | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 7 similar websites and full traffic analytics for Life Length
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 7 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Genomics & Gene Therapy Platforms
3 companies that operate in the same segment as Life Length (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Life Length
Complete news archive for Life Length
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Life Length
Life Length was founded in 2010 and raised its 1st funding round 5 years after it was founded.
Life Length is headquartered in Bensalem, United States. It is registered at Bensalem, Pennsylvania, United States.
Stephen J Matlin is the CEO of Life Length, as recorded in our data. They have also founded this company.
Life Length is a funded company, having raised a total of $2.7M across 6 funding rounds to date. The company's 1st funding round was a Grant of $56.47K, raised on Sep 2015.
Provides telomere length analysis technology for diagnosis. The company offers its proprietary technology for telomerase length detection for the health and aging process. It offers its services to physicians, individuals, researchers, and corporations. The company is involved in the development of biomarkers and its flagship product ONCOCHECK for clinical validation of Telomere Associated Variables (TAVs) as cancer biomarkers by its TAT technology for prostate cancer.
Life Length's top competitors include Maze Therapeutics, Metabolon and Seer.
Life Length offers HealthTAV, HealthNAD+, and HealthOX.
Life Length has 3 investors. Key investors include European Union, EMPLEO COMUNIDAD DE MADRID, and EIC Fund.